Indian Pharmacopoeia 2022 Pdf Free Download

In this post 4 Volume of Indian Pharmacopoeia 2022 Pdf Free Download are avilable for free download.

Indian Pharmacopoeia 2022 Pdf Free Download

The Indian Pharmacopoeia Commission (IPC) on behalf of the Ministry of Health & Family Welfare, Government of India, has issued the Indian Pharmacopoeia, Ninth Edition (IP 2022). In order to comply with the provisions of the Drugs and Cosmetics Act, 1940 and its implementing rules, the Indian Pharmacopoeia (IP) is issued. It establishes the requirements for medications made in India and/or marketed there, which helps to regulate and guarantee the high quality of the medications. The pharmacopoeia's standards are binding and enforceable in court. It aims to support the licensing of pharmaceutical manufacturing, inspection, and distribution. IP is issued in furtherance of IPC's aim to improve public health by ensuring the quality, safety, and efficacy of medications.

Indian Pharmacopoeia 2022

The Indian Pharmacopoeia comprises specifications and analytical processes for evaluating the quality of pharmaceutical ingredients, excipients, and dosage forms: The definition, description, identification, specific tests, assays, packaging, storage, labelling specifications, impurities profile, one or more analytical procedures for each test, acceptance criteria, and other requirements are all included in the IP monograph for an official substance or preparation. The East India Company's Dispensary's Committee first suggested the publication of a pharmacopoeia in 1833, and the Bengal Pharmacopoeia and General Conspectus of Medicinal Plants, which primarily listed the majority of the commonly used indigenous remedies, were published in 1844.

People Also Serach: Indian Pharmacopoeia 2018

People Also Serach: Indian Pharmacopoeia 2010

The British Pharmacopoeia (BP) 1867 and indigenous medications used in India were covered by IP 1868, which was followed by a Supplement published in 1869 that included the vernacular names of indigenous pharmaceuticals and plants. However, the BP became recognised in India as of 1885. A National Pharmacopoeia was suggested for publishing by the Government's Drugs Enquiry Committee, which was established in 1927.

Following independence, the Indian Pharmacopoeia Committee was established in 1948 with the primary goal of publishing IP. The first edition of IP was published in 1955, and a Supplement was issued in 1960.

The same policy was followed when the second edition of the Indian Pharmacopoeia, published in 1966, and its Supplement, published in 1975, were being prepared. This pharmacopoeia included both western and traditional systems of medications that were often used in India. Since Indian independence, particularly from the beginning of 1970, the sector has experienced spectacular expansion and development, both in terms of the variety of Active Pharmaceutical Ingredients (APFS) available and the dosage forms created. As a result, the Indian pharmaceutical industry underwent a complete transformation, becoming one of the major international providers of pharmaceutical goods to both developed and developing nations. The successive editions and supplements of IP attempted to address these developments, which posed significant hurdles for IP to accurately reflect the quality standards of the marketed pharmaceuticals.

The Indian Pharmacopoeia Committee was created in 1978 in order to produce new editions of the Pharmacopoeia and its Addenda at more frequent and shorter intervals in light of these rapid advancements. The third edition of the Indian Pharmacopoeia was published in 1985, and its addenda were published in 1989 and 1991, respectively. Only those herbal pharmaceuticals with clear quality control criteria were included in it, while the majority of newly created and/or marketed drugs were included. The fourth version of IP 1996, its Addendum 2000, Supplement 2000 for Veterinary Products, and Addendum 2002 were developed in light of the rapidly expanding variety of pharmaceuticals produced in India.

The Addendum 2005, which was released by the IPC and contained a significant number of antiretroviral medications and raw materials frequently used in pharmaceutical production but not listed by any other pharmacopoeias, garnered considerable international attention. Based on the therapeutic value, medical need, and volume of use of such articles in the nation, the IP Committee decided to erase the product monographs for outmoded or infrequently used products and add new product monographs.

In 2005, the Indian Pharmacopoeia Commission was founded. With a focus on those medications and formulations that cover National Health Care Programmes and the National Essential Medicines, it provided a systematic approach and practises for publishing the fifth edition of IP 2007 with 271 new monographs. It also included an addendum to IP 2007 from 2008 that contained 72 new monographs.

Monographs on antiviral, anticancer, antituberculosis, and herbal medications were included in the sixth edition of IP 2010. It also placed a strong emphasis on biological monographs, including those on vaccines, human-use immunoglobulins, blood products, and veterinary (both biological and non-biological) preparations. The IP 2010 Addendum 2012, which included 52 additional monographs and addressed the IP 2010 Amendments, was published.

The seventh edition of the Indian Pharmacopoeia, which included 577 monographs on APIs, excipients, dosage forms, radiopharmaceuticals, herbal, and veterinary goods, was released in 2014.

The sixth edition of IP 2010 included monographs on herbal, anticancer, antituberculosis, and anti-retroviral medications. Additionally, it placed a focus on biological monographs, including those on vaccines, human immunosera, blood products, biotechnological, and veterinary (both biological and non-biological) preparations. The IP 2010 was updated with Addendum 2012, which included 52 additional monographs and addressed the IP 2010 Amendments.

A total of 577 monographs covering APIs, excipients, dosage forms, radiopharmaceuticals, herbal, and veterinary products were included in the seventh edition of the Indian Pharmacopoeia, which was released in 2014.

Indian Pharmacopoeia 2022 Pdf Free Download Updated

The current monographs should be updated, and new monographs of drug compounds based on clinical use of medications in India and improved test methodologies should be included. By using cutting-edge technology, the IP 2022 has been significantly altered and improved with regard to the needs of monographs, general chapters, dosage form monographs, and testing protocols. The general chapters' and dosage form monographs' contents have generally been updated to reflect those used internationally. Special focus has been placed on the monographs of mixed dose formulations that are commonly marketed in India.

In order to make this edition precise and well-organized, focus has also been placed on bringing out harmonization in the appendices to establish a solid relationship between particular monographs and the pertinent appendices. The number of monographs and appendices has increased to reflect the most recent developments in technology and regulatory compliance. By adding monographs for fixed dose combination medications, adopting modern methods, and keeping up with rapidly evolving technology standards, ongoing attempts have been undertaken to harmonies national drug standards and gradually bring them into compliance with international standards.

New Features

New Monographs: 92  
APIs: 27
Dosage Forms (Chemicals): 33
Vitamins, Minerals, Amino acids, Fatty Acids etc.: 21
Biotechnology Derived Therapeutic products: 03
Herbs & Herbal Products: 02
Blood & Blood Related Products: 02
Vaccines and Immunosera for human use: 04
General Chapters: 12

2-Deoxy-D-Glucose 2-Deoxy-D-Glucose Sachet Amifostine Amifostine for Injection
Amlodipine and Valsartan Tablets Apremilast Apremilast Tablets Aprotinin Injection
Azithromycin Eye Drops Bosutinib Bosutinib Tablet Brivaracetam
Brivaracetam Brivaracetam Tablets Ceftriaxone and Sulbactam for Injection Desogestrel
Desogestrel and Ethinyl Estradiol Tablets Dextran 1 Dextran 40 Dextran 70
Dextropropoxyphene Hydrochloride and Paracetamol Tablets Diclofenac Potassium Diclofenac Potassium Tablets Epalrestat
Epalrestat Tablets Estradiol Hemihydrate Ethyl Acetate Ethynodiol Diacetate
Ethynodiol Diacetate and Ethinyl Estradiol Tablets Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Prolonged-release Tablets Glipizide and Metformin Tablets Itraconazole
Lenvatinib Mesylate Lenvatinib Capsules Mesna Tablets Oxetacaine
Polymyxin B Sulphate Polymyxin B for Injection Prasugrel and Aspirin Gastro-resistant Capsules Repaglinide and Voglibose Tablets
Ribavirin Capsules Risperidone Syrup Rocuronium Bromide Rocuronium Injection
Sodium Starch Glycolate (Type B) Sofosbuvir Sofosbuvir and Daclatasvir Tablets Sofosbuvir Tablets
Sugar Spheres Tofacitinib Citrate Tofacitinib Tablets Trazodone Hydrochloride
Trazodone Tablets Teneligliptin and Metformin Hydrochloride Prolonged-release Tablets Triamterene and Hydrochlorothiazide Tablets Valacyclovir Hydrochloride
Valacyclovir Tablets Valganciclovir Hydrochloride Valganciclovir Tablets Vildagliptin and Metformin Tablets

Previous Post Next Post